CV
Effective applications of botulinum toxin in dentistry and in head and neck surgery
Review Articles
References
1. Chapman P. The global botox market forecast to reach $ 2.9 billion by 2018. http:// www. businesswire. com / news / home / 20120515006631 / en / Research-Markets- Global-Botox-Market-Forecast-Reach
2. Roy D, Sadick NS. Complications of Botulinum Toxin. In: Gloster Jr. HM, Editor. Complications in Cutaneous Surgery. New York, NY. Springer; 2008.
3. Blitzer A, Sulica L. Botulinum toxin: basic science and clinical uses in otolaryngology. Laryngoscope. 2001; 111( 2): 218-226. doi: 10.1097 / 00005537- 200102000-00006 [ Full text links ] [ PubMed ]
4. Apostolidis A, Popat R, Yiangou Y, et al. Decreased sensory receptors P2X 3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol. 2005; 174( 3): 977-982; discussion 982-983. doi: 10.1097 / 01. ju. 0000169481.42259.54 [ Full text links ] [ PubMed ]
5. Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc. 1981; 79:734 – 770. [ Full text links ] [ Free PMC article ] [ PubMed ]
6. Clark RP, Berris CE. Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis. Plast Reconstr Surg. 1989; 84( 2): 353-355. [ PubMed ]
7. Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol. 1992; 18( 1): 17-21. [ PubMed ]
8. Information for Healthcare Professionals: OnabotulotoxinA( marketed as Botox / Botox Cosmetic), AbobotulotoxinA( marketed as Dysport) and RimabotulotoxinB( marketed as Myobloc). Food and Drug Administration( United States), 2009- 08-03. https:// www. fda. gov / Drugs / DrugSafety / PostmarketDrugSafetyInformationforPatientsand Providers / DrugSafetyInformationforHeathcareProfessionals / ucm174949. htm
9. Schames J, Dov Prero Y, Schames D, et al. Uncontrollable distant effects of botulinum neurotoxin injections. J Calif Dent Assoc. 2009; 37( 1): 44-45. [ PubMed ]
10. Sycha T, Kranz G, Auff E, Schnider P. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature. J Neurol. 2004; 251 Suppl 1: I19-30. [ Full text links ] [ Free PMH article ] [ PubMed ]
11. Jackson JL, Kuriyama A, Hayashino Y. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis. JAMA. 2012; 307( 16): 1736-1745. doi: 10.1001 / jama. 2012.505. [ Full text links ] [ Free PMH article ] [ PubMed ]
12. Finzi E, Wasserman E. Treatment of depression with botulinum toxin A: a case series. Dermatol Surg. 2006; 32( 5): 645-649; discussion 649-650. doi: 10.1111 / j. 1524-4725.2006.32136. x [ Full text links ] [ PubMed ]
13. Keegan DJ, Geerling G, Lee JP, et al. Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation. Br J Ophthalmol. 2002; 86( 1): 43-46.
[ Free full text ] [ Free PMC article ] [ PubMed ]
14. Adour KK, Bell DN, Hilsinger RL Jr. Herpes simplex virus in idiopathic facial paralysis( Bell palsy). JAMA. 1975; 233( 6): 527-530. [ Full text links ] [ PubMed ]
15. Park MY, Ahn KY, Jung DS. Botulinum toxin type A treatment for contouring of the lower face. Dermatol Surg. 2003; 29( 5): 477-483; discussion 483. [ Full text links ] [ PubMed ]
16. Tan EK, Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc. 2000; 131( 2): 211- 216. [ Full text links ] [ PubMed ]
17. Moore AP, Wood GD. The medical management of masseteric hypertrophy with botulinum toxin type A. Br J Oral Maxillofac Surg. 1994; 32( 1): 26-28. [ PubMed ]
18. Persaud R, Garas G, Silva S, et al. An evidence-based review of botulinum toxin( Botox) applications in noncosmetic head and neck conditions. JRSM Short Rep. 2013; 4( 2): 10. doi: 10.1177 / 2042533312472115. [ Free PMC article ] [ PubMed ]
19. Chikhani L, Dichamp J. [ Bruxism, temporo-mandibular dysfunction and botulinum toxin ]. Ann Readapt Med Phys. 2003; 46( 6): 333-337. [ Full text links ] [ PubMed ]
20. Zúñiga C, Díaz S, Piedimonte F, Micheli F. Beneficial effects of botulinum toxin type A in trigeminal neuralgia. Arq Neuropsiquiatr. 2008; 66( 3A): 500-503. [ Full text links ] [ PubMed ]
21. Ellies M, Gottstein U, Rohrbach-Volland S, et al. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis. Laryngoscope. 2004; 114( 10): 1856-1860. doi: 10.1097 / 00005537- 200410000-00033 [ Full text links ] [ PubMed ]
22. Conill Tobías N, de Paula Vernetta C, García Callejo FJ, Marco Algarra J. Objective tinnitus from palatal myoclonus. Use of botulinum toxin: a case report. Acta Otorrinolaringol Esp. 2012; 63( 5): 391-392. doi: 10.1016 / j. otorri. 2011.02.004 [ Full text links ] [ Free full text ] [ PubMed ]
23. Polo M. Botulinum toxin type A( Botox) for the neuromuscular correction of excessive gingival display on smiling( gummy smile). Am J Orthod Dentofacial Orthop. 2008; 133( 2): 195-203. doi: 10.1016 / j. ajodo. 2007.04.033. [ Full text links ] [ PubMed ]
24. Aly LA, Hammouda NI. Botox as an adjunct to lip repositioning for the management of excessive gingival display in the presence of hypermobility of upper lip and vertical maxillary excess. Dent Res J( Isfahan). 2016; 13( 6): 478-483. [ Full text links ] [ Free PMC article ] [ PubMed ]
25. Goldman A, Wollina U. Elevation of the corner of the mouth using botulinum toxin type A. J Cutan Aesthet Surg. 2010; 3( 3): 145-150. doi: 10.4103 / 0974- 2077.74490. [ Free full text ] [ Free PMC article ] [ PubMed ]
26. Dogu O, Apaydin D, Sevim S, et al. Ultrasoundguided versus‘ blind’ intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson’ s disease. Clin Neurol Neurosurg. 2004; 106( 2): 93-96. doi: 10.1016 / j. clineuro. 2003.10.012 [ Full text links ] [ PubMed ]
Roman ŠMUCLER
DDS, PhD, Associate Professor Department of Stomatology
Medical Faculty, Charles University Prague, Czech Republic
CV
Roman Šmucler graduated from the First School of Medicine, Charles University, Prague. He is an Oral Surgeon and a specialist in Aesthetic and Laser Medicine( PDT, BTX, Lasers, Dental implants) as well as a professor of Medical Business. Associate Professor at Charles University Prague; Associate Professor at University of PJ Safarik, Kosice. President of the Czech Dental Chamber. Chair of the Czech Society of Aesthetic and Laser Medicine; Board member of IMCAS Academy; Member or Fellow of the American Society for Laser Medicine and Surgery, Inc.( ASLMS), American Academy of Implant Dentistry( AAID), American Academy of Cosmetic Dentistry( AACD), ELA.
206
Stoma Edu J. 2017; 4( 3): 200-207 http:// www. stomaeduj. com